Ariana Boswell

All articles by Ariana Boswell

• Study: HPA data alone may not predict FNAIT risk

  A study of genetic data from the Saudi population found that the predicted risk of FNAIT does not always align with observed outcomes.

• Understanding FNAIT caused by HPA-5b vs HPA-1a antibodies

  Learn more about the difference between FNAIT caused by HPA-5b vs HPA-1a antibodies, including prevalence, treatment options and more.

• New tool can detect over 50 markers to improve FNAIT diagnosis

  Scientists developed a new technique to detect platelet antigens linked to FNAIT and quantify fetal DNA in maternal blood samples.

• High anti-HPA-1a levels may up risk of neonatal brain bleeds

  Researchers in Norway called for countries to update their guidelines to include consideration of anti-HPA-1a levels when treating FNAIT.

• Immune thrombocytopenia in late pregnancy requires specialized care

  A study presents six cases of pregnant women with severe ITP, highlighting the importance of individualized treatment to improve outcomes.

• Can prednisone cause gestational diabetes? 

  Prednisone is sometimes prescribed as a treatment for FNAIT, but in some patients, it can lead to gestational diabetes.

• Case report: Simple platelet tests can help diagnose FNAIT

  In areas where the MAIPA test is unavailable, platelet crossmatching can be a useful tool for diagnosing FNAIT.

• Why some patients may need more IVIG infusions than others

  Learn more about why IVIG is recommended for pregnancies at risk of FNAIT and why some patients may need more infusions than others.

• Clinical trial to determine whether nipocalimab can prevent FNAIT

  A clinical trial sponsored by Johnson & Johnson will seek to determine whether nipocalimab prevents or delays FNAIT in at-risk pregnancies.

• Maternal thrombocytopenia linked to greater risk of infant thrombocytopenia

  A recent study found that severe maternal thrombocytopenia may increase the risk of neonatal thrombocytopenia.